A new study finds semaglutide is linked to an increased risk of vision loss associated with a rare eye condition, but cases remain rare. Here's what experts want you to know.

The Danish Medicines Agency requested the EMA's Pharmacovigilance Risk Assessment Committee review reports on the ...

Decreased blood flow of the optic nerve head (MA, MV, and MT measurements) was significantly correlated with increased OSA ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Researchers have established that the application of once-weekly semaglutide in patients with type 2 diabetes (T2D) increases ...

GA management involves identifying at-risk patients, assessing visual function, and referring for treatment when necessary.

Acute limb ischemia occurs due to a sudden decrease in the blood flow to a limb, resulting in a potential threat to the viability of the extremity. Unfortunately, the threat is not only to the ...

Two new studies suggest that the diabetes medication Ozempic may double the risk of a rare but serious condition that damages the optic nerve.

Some eye doctors were noticing a trend among patients that researchers in Europe now believe has been well demonstrated with ...

How to Choose the Best Hair Loss Treatment for You Finding the right hair loss treatment depends on the type and severity of your hair loss. With so many options available, it’s important to ...

cervical brachial neuropathy and lumbar radiculopathy, as well as studies with PRFA or TRF ablation. The high-quality studies showed that thermal RFA of the DRG is not effective in the treatment ...